|
AU2016203713A1
|
|
Solid compositions and methods for treating middle-of-the night insomnia
|
|
AU2012238306A1
|
|
Solid compositions and methods for treating middle-of-the night insomnia
|
|
WO2012075288A1
|
|
Method of treatment of obsessive compulsive disorder with ondansetron
|
|
WO2012071220A1
|
|
Compositions and methods for once-daily administration of a trilayer osmotic tablet
|
|
WO2010068789A1
|
|
Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
|
|
US2008132535A1
|
|
Stabilized Zolpidem Pharmaceutical Compositions
|
|
US2008004260A1
|
|
Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions
|
|
US2007287740A1
|
|
Compositions and methods of treating middle-of-the night insomnia
|
|
ZA200710205B
|
|
Solid compositions and methods for treating middle-of-the night insomnia
|
|
AU2006249761A1
|
|
Solid compositions and methods for treating middle-of-the night insomnia
|
|
NZ548856A
|
|
Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
|
|
KR20160105935A
|
|
Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
|
